CLASS II Device recall · Reported 26 Feb 2020 · FDA Enforcement Report

Optilite IgM Kit recalled by The Binding Site Group

The Binding Site Group is recalling Optilite IgM Kit, distributed in 28 states. The recall was initiated on 29 Jul 2019 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot # 422251
Quantity recalled3294 kits

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1327-2020
FDA event ID
84729
Recalling firm
The Binding Site Group, Birmingham
Classification
Class II
Status
Terminated
Recall initiated
29 Jul 2019
FDA classified
19 Feb 2020
Reported
26 Feb 2020
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Other Reasons

Timeline

29 Jul 2019Recall initiated by company
19 Feb 2020Classified by FDA+205 days
26 Feb 2020Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

There is a potential that users may experience difficulty validating the calibration of the kit. This is indicated by kit control values reporting outside the specified ranges. This could result in potential false patient results which could cause a delay until repeat testing is performed.

Product as listed by the FDA

OPTILITE IgM Kit, REF: NK012.OPT.A, IVD, UDI: 05051700017565

Where it was distributed

CA, PA, FL, AR, SD, MA, WV, AL, GA, IL, MN, MD, AZ, NC, TN, WA, MI, NY, KY, SC, IN, OR, NE, OH, TX, VT, WA, UT, IA,

AlabamaArkansasArizonaCaliforniaFloridaGeorgiaIowaIllinoisIndianaKentuckyMassachusettsMarylandMichiganMinnesotaNorth CarolinaNebraskaNew YorkOhioOregonPennsylvania

Questions about this recall

Why was it recalled?

There is a potential that users may experience difficulty validating the calibration of the kit. This is indicated by kit control values reporting outside the specified ranges. This could result in potential false patient results which could cause a delay until repeat testing is performed.

Which lots are affected?

Lot # 422251

Where was it sold?

CA, PA, FL, AR, SD, MA, WV, AL, GA, IL, MN, MD, AZ, NC, TN, WA, MI, NY, KY, SC, IN, OR, NE, OH, TX, VT, WA, UT, IA,

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from The Binding Site Group

All 29

Other Other Medical Devices recalls

All 13,950